GWAYF (Greenway Greenhouse Cannabis) Research & Development: $0.02 Mil (TTM As of Dec. 2025)


GWAYF Greenway Greenhouse Cannabis Corp GWAYF
24 GF Score
Price $0.10
GF Value $0.28
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Greenway Greenhouse Cannabis Research & Development?

Greenway Greenhouse Cannabis GWAYF +0.94% 24 Research & Development is $0.02 Mil as of Dec. 2025. GuruFocus rates GWAYF with a GF Score™ of 24/100 and a GF Value™ of $0.28 (Possible Value Trap). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Greenway Greenhouse Cannabis's Research & Development for the three months ended in Dec. 2025 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0.02 Mil.

Greenway Greenhouse Cannabis  (OTCPK:GWAYF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Greenway Greenhouse Cannabis Research & Development Related Terms

Greenway Greenhouse Cannabis Research & Development Historical Data

* Premium members only.

The historical data trend for Greenway Greenhouse Cannabis's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Greenway Greenhouse Cannabis Research & Development Chart

Greenway Greenhouse Cannabis Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Research & Development
0.01 0.04 0.00 0.00 0.05

Greenway Greenhouse Cannabis Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.00 0.00 0.00
GWAYF
24GF Score
Greenway Greenhouse Cannabis Corp GWAYF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Greenway Greenhouse Cannabis Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.02 Mil mean?
Greenway Greenhouse Cannabis (GWAYF) has a Research & Development of $0.02 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Greenway Greenhouse Cannabis and its competitors.
Is Greenway Greenhouse Cannabis' Research & Development too high?
Greenway Greenhouse Cannabis' current Research & Development is $0.02 Mil. Overall, Greenway Greenhouse Cannabis has a GF Score™ of 24/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Greenway Greenhouse Cannabis' Research & Development compare to ZTS and UTHR?
Greenway Greenhouse Cannabis' Research & Development of $0.02 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Greenway Greenhouse Cannabis and its competitors. Greenway Greenhouse Cannabis's current Research & Development is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greenway Greenhouse Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Greenway Greenhouse Cannabis (GWAYF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.28, compared to a current price of $0.10 — trading 63.6% below its estimated fair value. The current Research & Development is $0.02 Mil. Greenway Greenhouse Cannabis' overall GF Score™ is 24/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Greenway Greenhouse Cannabis (GWAYF), the current Research & Development is $0.02 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Greenway Greenhouse Cannabis (GWAYF) Overvalued in 2026?

Based on GuruFocus' analysis, Greenway Greenhouse Cannabis stock appears to be undervalued. The current stock price of $0.10 is trading 63.6% below its estimated GF Value™ of $0.28. GuruFocus considers Greenway Greenhouse Cannabis to be Possible Value Trap.

Key valuation signals for GWAYF:

  • Research & Development: $0.02 Mil
  • GF Value™: $0.28 vs. price of $0.10 (63.6% below fair value)
  • GF Score™: 24/100 with 5 warning signs

No single metric tells the full story. See the GWAYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Greenway Greenhouse Cannabis Business Description

Other Exchanges GWAY:Canada
Address 1478 Seacliff Drive, Kingsville, ON, CAN, N9Y 2M2
Greenway Greenhouse Cannabis Corp is licensed to cultivate, process and sell to ensures harvests always consist of the highest quality cannabis strains with resinous flowers, trichomes, and rich cannabinoid profiles. The Company's nursery facility is located in Kingsville, Ontario, and its flowering and processing facility is located in Leamington, Ontario. The business model is to supply bulk packaged, high quality cannabis to the Canadian, cannabis industry at prices that ultimately provide a value proposition to the consumers. Greenway has three divisions with various locations; Greenway Nursery, Greenway Cultivation and future plans for Greenway Farmgate Retail Store.
24GF Score

Get the complete analysis for GWAYF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10
Price
$0.28
GF Value